✦ LIBER ✦

Progressive Myeloma after Thalidomide Therapy in a Patient with Immature Phenotype of Myeloma (Plasma) Cells

✍ Scribed by Yoshiko Okikawa; Akira Sakai; Yasuo Takimoto; Masaaki Noda; Jun Imagawa; Yuta Katayama; Yoshiaki Kuroda; Hajime Okita; Kingo Fujimura; Akiro Kimuraa

Book ID: 111835326
Publisher: Carden Jennings Publishing
Year: 2004
Tongue: English
Weight: 613 KB
Volume: 79
Category: Article
ISSN: 0925-5710
DOI: 10.1532/ijh97.04005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Thalidomide plus dexamethasone as a main

Thalidomide plus dexamethasone as a maintenance therapy after autologous hematopoietic stem cell transplantation improves progression-free survival in multiple myeloma

✍ Angelo Maiolino; Vania T.M. Hungria; Marcia Garnica; Gislaine Oliveira-Duarte; L 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 443 KB

Thalidomide and dexamethasone therapy of

Thalidomide and dexamethasone therapy of myeloma in a patient with previously untreated B-chronic lymphocytic leukemia

✍ James C. Barton 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 2 views

## Abstract A 67‐year‐old woman with previously untreated lambda‐positive B‐chronic lymphocytic leukemia (CLL) had kappa‐positive myeloma develop that was treated with daily thalidomide and intermittent dexamethasone. After 4 months, there was a marked reduction in marrow plasmacytosis, urine kappa

Unusual cutaneous involvement during pla

Unusual cutaneous involvement during plasma cell leukaemia phase in a multiple myeloma patient after treatment with thalidomide: a case report and review of the literature

✍ D. T. Alexandrescu; L. Koulova; P. H. Wiernik 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 291 KB

Long-term thalidomide therapy resulted i

Long-term thalidomide therapy resulted in lack of mdr1 gene expression in a patient with primary resistant multiple myeloma

✍ Hus, M; Dmoszyñska, A; Kocki, J; Hus, I; Jawniak, D; Adamczyk-Cioch, M; Grzasko, 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 99 KB

Thalidomide, dexamethasone and lovastati

Thalidomide, dexamethasone and lovastatin with autologous stem cell transplantation as a salvage immunomodulatory therapy in patients with relapsed and refractory multiple myeloma

✍ Marek Hus; Norbert Grzasko; Marta Szostek; Andrzej Pluta; Grzegorz Helbig; Dariu 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 218 KB

Molecular monitoring of the tumor load p

Molecular monitoring of the tumor load predicts progressive disease in patients with multiple myeloma after high-dose therapy with autologous peripheral blood stem cell transplantation

✍ Lipinski, E; Cremer, F W; Ho, A D; Goldschmidt, H; Moos, M 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 172 KB